Cough & Cold Medicine Manufacturing OTC
Cough and cold medicine manufacturers benefited from an increasing number of consumers purchasing over-the-counter (OTC) medications as a form of self-treatment for their health ailments. The accessibility, affordability and reliability of OTC medications drove industry growth during the current period. More importantly, revenue growth was fueled by a number of prescription allergy medications switching to OTC. Consequently, over the five years to 2017, industry revenue is anticipated to grow. Over the five years to 2022, this growth is expected to continue, though due to rising demand for cough and cold medication, the industry is expected to contend with rising external competition from private-label products sold in drug stores and online.
This industry manufactures over-the-counter (OTC) cough and cold treatments and suppressants. Products include systemic remedies like antihistamines and combination products, decongestants and medicated candies. The industry does not include companies that are primarily retailers, like pharmacies or department stores.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook